enkephalin, ser(2), leu(5), thr(6)- has been researched along with thiazoles in 1 studies
Studies (enkephalin, ser(2), leu(5), thr(6)-) | Trials (enkephalin, ser(2), leu(5), thr(6)-) | Recent Studies (post-2010) (enkephalin, ser(2), leu(5), thr(6)-) | Studies (thiazoles) | Trials (thiazoles) | Recent Studies (post-2010) (thiazoles) |
---|---|---|---|---|---|
224 | 0 | 5 | 33,179 | 2,100 | 12,330 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Martin-Kleiner, I | 1 |
1 other study(ies) available for enkephalin, ser(2), leu(5), thr(6)- and thiazoles
Article | Year |
---|---|
The effect of opioid agonists of delta-class DSLET, mu-class DAMGO, kappa-class U-69593 and an opioid antagonist, naloxone, on MTT activity of NALM-1 leukemic cells.
Topics: Benzeneacetamides; Cell Division; Cell Survival; Colorimetry; DNA Fragmentation; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalin, Leucine; Humans; Leukemia; Naloxone; Narcotic Antagonists; Pyrrolidines; Receptors, Opioid, delta; Receptors, Opioid, kappa; Receptors, Opioid, mu; Tetrazolium Salts; Thiazoles; Tumor Cells, Cultured | 2002 |